Pranza, Abegail .

HRN: 23-79-97  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2023
AMPICILLIN 1GM (VIAL)
10/24/2023
10/27/2023
IV
2 G
Q6
Thickly MSAF PROM
Waiting Final Action 
10/26/2023
CEFUROXIME 500MG (TAB)
10/26/2023
11/02/2023
PO
500mg Tab
BID
TMSAF
Waiting Final Action 
10/26/2023
METRONIDAZOLE 500MG (TAB)
10/26/2023
11/02/2023
PO
500mg Tab
TID
Thickly Meconium Stained Amniotic Fluid
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: